Therefore, we assessed PD-1 and CTLA-4 expression in the peripheral blood (PB) CD4+ T cell subsets involved in the antitumor response in MM patients at disease diagnosis and relapse. The gene discussed is CTLA4; the disease is Miyoshi myopathy.